Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:32 PM
Ignite Modification Date:
2025-12-24 @ 12:32 PM
NCT ID:
NCT04776161
Eligibility Criteria:
Inclusion Criteria:
* English-speaking patients
* receiving their care at a Brigham and Women's Hospital-affiliated rheumatology practice
* \>=18 years of age
* with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), or gout
* prescribed \>=1 oral medication for this disease for \>=4 months.
* for patients with gout, had a uric acid level checked in the prior 18 months and the most recent level is \>6.
* for patients with SLE, their most recent c-reactive protein level collected in the past 18 months must be \>10.
* currently have a smartphone with a data plan or WiFi at home
* willing and able to set up the platform and adhere to study procedures
* either not currently using a pillbox or willing to use electronic pill bottles (EDMs) for diabetes medications for the duration of the study
Exclusion Criteria:
* Pregnant women
* Incarcerated individuals
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT04776161
Study Brief:
Protocol Section:
NCT04776161